|
1
|
Young AN, Jacob E, Willauer P, Smucker L,
Monzon R and Oceguera L: Anal Cancer. Surg Clin North Am.
100:629–634. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Babiker HM, Kashyap S, Mehta SR, Lekkala
MR and Cagir B: Anal Cancer. 2024. View Article : Google Scholar
|
|
3
|
Morton M, Melnitchouk N and Bleday R:
Squamous cell carcinoma of the anal canal. Curr Probl Cancer.
42:486–492. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gnanajothy R, Warren GW, Okun S and
Peterson LL: A combined modality therapeutic approach to metastatic
anal squamous cell carcinoma with systemic chemotherapy and local
therapy to sites of disease: Case report and review of literature.
J Gastrointest Oncol. 7:E58–E63. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sawai K, Goi T, Tagai N, Kurebayashi H,
Morikawa M, Koneri K, Tamaki M, Murakami M, Hirono Y and Maeda H:
Stage IV anal canal squamous cell carcinoma with Long-term
survival: A case report. Surg Case Rep. 8:1192022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Malla M, Hatoum H and George S: Brain
metastases in anal squamous cell carcinoma: Case report and review
of the literature. J Clin Images Med Case Rep. 32022.PubMed/NCBI
|
|
7
|
Ogawa S, Fujishiro H, Fujiwara A, Tsukano
K, Kotani S, Yamanouchi S, Kusunoki R, Aimi M, Miyaoka Y, Kohge N
and Onuma H: A case of Long-term survival in stage IV squamous cell
carcinoma of the anal canal with multidisciplinary treatment. Nihon
Shokakibyo Gakkai Zasshi. 114:1987–1995, (In Japanese). PubMed/NCBI
|
|
8
|
Chihabeddine M, Naim A, Habi J, Kassimi M,
Mahi M and Kouhen F: Anal cancer with atypical brain and cranial
bones metastasis: About 2 cases and literature review. Case Rep
Oncol. 14:778–783. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gassman AA, Fernando E, Holmes CJ, Kapur U
and Eberhardt JM: Development of cerebral metastasis after medical
and surgical treatment of anal squamous cell carcinoma. Case Rep
Oncol Med. 2012:9121782012.PubMed/NCBI
|
|
10
|
Rughani AI, Lin C, Tranmer BI and Wilson
JT: Anal cancer with cerebral metastasis: A case report. J
Neurooncol. 101:141–143. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Davidson NG and Yong PP: Brain metastasis
from basaloid carcinoma of the anal canal 8 years after
abdominoperineal resection. Eur J Surg Oncol. 17:227–230.
1991.PubMed/NCBI
|
|
12
|
Klotz RG, Pamukcoglu T and Souilliard DH:
Transitional cloacogenic carcinoma of the anal canal.
Clinicopathologic study of three hundred Seventy-three cases.
Cancer. 20:1727–1745. 1967. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hernando-Cubero J, Alonso-Orduña V,
Hernandez-Garcia A, De Miguel AC, Alvarez-Garcia N and Anton-Torres
A: Brain metastasis in basaloid undifferentiated anal carcinoma: A
case report. Oncol Lett. 7:1276–1278. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mai S, Welzel G, Ottstadt M, Lohr F,
Severa S, Prigge ES, Wentzensen N, Trunk MJ, Wenz F, von
Knebel-Doeberitz M and Reuschenbach M: Prognostic relevance of HPV
infection and p16 overexpression in squamous cell anal cancer. Int
J Radiat Oncol Biol Phys. 93:819–827. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rami S, Han YD, Jang M, Cho MS, Hur H, Min
BS, Lee KY and Kim NK: Efficacy of Immunohistochemical staining in
differentiating a squamous cell carcinoma in poorly differentiated
rectal cancer: Two case reports. Ann Coloproctol. 32:1502016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
van der Zee RP, Richel O, de Vries HJC and
Prins JM: The increasing incidence of anal cancer: Can it be
explained by trends in risk groups? Neth J Med. 71:401–411.
2013.PubMed/NCBI
|
|
17
|
Sclafani F, Hesselberg G, Thompson SR,
Truskett P, Haghighi K, Rao S and Goldstein D: Multimodality
treatment of oligometastatic anal squamous cell carcinoma: A case
series and literature review. J Surg Oncol. 119:489–496. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gondal TA, Chaudhary N, Bajwa H, Rauf A,
Le D and Ahmed S: Anal cancer: The past, present and future.
Current Oncol. 30:3232–3250. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Meulendijks D, Tomasoa NB, Dewit L, Smits
PHM, Bakker R, van Velthuysen MLF, Rosenberg EH, Beijnen JH,
Schellens JH and Cats A: HPV-negative squamous cell carcinoma of
the anal canal is unresponsive to standard treatment and frequently
carries disruptive mutations in TP53. Br J Cancer. 112:1358–1366.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rayess H, Wang MB and Srivatsan ES:
Cellular senescence and tumor suppressor gene p16. Int J Cancer.
130:1715–1725. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Izadi-Mood N, Asadi K, Shojaei H, Sarmadi
S, Ahmadi SA, Sani S and Chelavi LH: Potential diagnostic value of
P16 expression in premalignant and malignant cervical lesions. J
Res Med Sci. 17:428–433. 2012.PubMed/NCBI
|
|
22
|
Mai S, Welzel G, Ottstadt M, Lohr F,
Severa S, Prigge ES, Wentzensen N, Trunk MJ, Wenz F, von
Knebel-Doeberitz M and Reuschenbach M: Prognostic relevance of HPV
infection and p16 overexpression in squamous cell anal cancer. Int
J Radiat Oncol Biol Phys. 93:819–827. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yoon G, Koh CW, Yoon N, Kim JY and Kim HS:
Stromal p16 expression is significantly increased in endometrial
carcinoma. Oncotarget. 8:4826–4836. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kettunen E, Savukoski S, Salmenkivi K,
Böhling T, Vanhala E, Kuosma E, Anttila S and Wolff H: CDKN2A copy
number and p16 expression in malignant pleural mesothelioma in
relation to asbestos exposure. BMC Cancer. 19:5072019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun G, Dong X, Tang X, Qu H, Zhang H and
Zhao E: The prognostic value of HPV combined p16 status in patients
with anal squamous cell carcinoma: A meta-analysis. Oncotarget.
9:8081–8088. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Stewart DB, Gaertner WB, Glasgow SC,
Herzig DO, Feingold D and Steele SR: The American society of colon
and rectal surgeons clinical practice guidelines for anal squamous
cell cancers (revised 2018). Dis Colon Rectum. 61:755–774. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Adams R: Surveillance of anal canal
cancers. Surg Oncol Clin N Am. 26:127–132. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Glynne-Jones R, Sebag-Montefiore D,
Meadows HM, Cunningham D, Begum R, Adab F, Benstead K, Harte RJ,
Stewart J, Beare S, et al: Best time to assess complete clinical
response after chemoradiotherapy in squamous cell carcinoma of the
anus (ACT II): A post-hoc analysis of randomised controlled phase 3
trial. Lancet Oncol. 18:347–356. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Zhong X, He X, Hu Z, Huang H, Chen
J, Chen K, Zhao S, Wei P and Li D: Liver metastasis from colorectal
cancer: Pathogenetic development, immune landscape of the tumour
microenvironment and therapeutic approaches. J Exp Clin Cancer Res.
42:1772023. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Riihimäki M, Hemminki A, Sundquist J and
Hemminki K: Patterns of metastasis in colon and rectal cancer. Sci
Rep. 6:297652016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tashima T: Brain cancer chemotherapy
through a delivery system across the Blood-brain barrier into the
brain based on Receptor-mediated transcytosis using monoclonal
antibody conjugates. Biomedicines. 10:15972022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhu W: Temozolomide for treatment of brain
metastases: A review of 21 clinical trials. World J Clin Oncol.
5:192013. View Article : Google Scholar
|
